Who owns Vaxcyte (PCVX)? Superinvestor holders
2 superinvestors of the 157 tracked here hold Vaxcyte (PCVX) in their latest 13F filing, with $760.8M between them. Peter Kolchinsky gives it the most weight: 5.80% of the reported portfolio. In their latest reported quarter, Lee Ainslie added.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Peter Kolchinsky, $667M
- Largest weight
- Peter Kolchinsky, 5.80%of their portfolio
- Combined value
- $760.8M
- Bought last quarter
- 1
- Sold last quarter
- 0
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Peter KolchinskyRA Capital Management | 5.80% | $667M | 11.47M | No change | 0 | Q2 2026 |
| 2 | Lee AinslieMaverick Capital | 0.85% | $93.8M | 1.61M | ▲ Added 17% | +235.46K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 0 | — | — | 0 | 0 |
| Q2 2026 | 157 | 2 | 13.09M | $760.8M | 1 | 2 |
| Q1 2026 | 157 | 4 | 14.91M | $866.6M | 4 | 0 |
| Q4 2025 | 157 | 3 | 12.08M | $557.5M | 2 | 2 |
| Q3 2025 | 157 | 3 | 13.9M | $500.5M | 0 | 1 |
| Q2 2025 | 157 | 3 | 13.92M | $452.5M | 1 | 1 |
| Q1 2025 | 156 | 3 | 14.04M | $530.1M | 3 | 2 |
| Q4 2024 | 156 | 4 | 10.03M | $820.7M | 2 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Peter Kolchinsky | · | 11.47M | 11.47M | 10.72M | 11.97M | 11.97M | 12.19M | 8.69M |
| Lee Ainslie | · | 1.61M | 1.38M | 1.35M | 1.29M | 1.31M | 1.21M | 1.2M |
| Andrew Spokes | — | — | 1.26M | 5K | — | — | — | — |
| Seth Klarman | — | — | 800K | — | — | — | — | — |
| Julian and Felix Baker | · | — | — | — | 640.89K | 640.89K | 640.89K | 48.89K |
| Stanley Druckenmiller | · | — | — | — | — | — | — | 86.27K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own PCVX?
In their latest 13F filings: Peter Kolchinsky (5.80% of the portfolio, $667M), Lee Ainslie (0.85% of the portfolio, $93.8M).
Who bought PCVX last quarter?
Lee Ainslie (added 17%). “Last quarter” is each investor's latest reported quarter.
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Vaxcyte (PCVX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/PCVX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to PCVX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.